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Isolation of Lineage-Restricted
Neuronal Precursors from Multipotent
Neuroepithelial Stem Cells
from pluripotent embryonic stem cells has not been ob-
served. Thus, the relationship between pluripotent stem
cells identified in culture and the committed precursors
identified in vivo and in vitro remain unknown. Pluripo-
tent and more committed stem cells may represent lin-
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The developing spinal cord represents an ideal model
for studying this differentiation. At embryonic day 10.5
(E10.5), the caudal neural tube appears as a homoge-Summary
neous population of nestin immunoreactive dividing cells
in vivo and in vitro. These initially homogeneous cellsWe have identified a neuronal-restricted precursor
are patterned over several days to generate neurons,(NRP) cell that expresses E-NCAM (high polysialic-
oligodendrocytes, and astrocytes in a characteristicacid NCAM) and is morphologically distinct from mul-
spatial and temporal profile. In the spinal cord, neuro-tipotent neuroepithelial (NEP)cells (Kalyani et al., 1997)
genesis occurs first ventrally, and progresses ventrodor-and spinal glial progenitors (Rao and Mayer-Proschel,
sally, with the earliest neurons becoming postmitotic on1997). NRP cells self renew over multiple passages in
E13.5 in rats (Wentworth, 1984; Altman and Bayer, 1984;the presence of fibroblast growth factor (FGF) and
Phelps et al., 1988; Phelps et al., 1990). Neurogenesis
neurotrophin-3 (NT-3) and differentiate in the presence
continues over an additional 2 days, followed by differ-
of retinoic acid and the absence of FGF into postmi- entiation of oligodendrocyte precursors and the subse-
totic neurons. NRP cells can also be generated from quent differentiation of astrocytes (Altman and Bayer,
multipotent E10.5 NEP cells. Clonal analysis shows 1984; Hirano and Goldman, 1988; Warf et al., 1991; Chen
that NRP cells arise from a NEP progenitor that gener- and Chiu, 1992; Fok-Seang and Miller, 1992; Noll and
ates other restricted CNS precursors. The NEP-derived Miller, 1993, 1994; Zangh and Miller, 1995). This sequen-
NRPs undergo self renewal and can differentiate into tial differentiation suggests that if intermediate neuronal
multiple neuronal phenotypes. Thus, a direct lineal re- restricted precursors exist, it should be possible to iso-
lationship exists between multipotential NEP cells and late these cells from E13.5 neural tubes. In contrast,
more restricted neuronal precursor cells present in isolation of cells from earlier spinal cords would likely
vivo at E13.5 in the spinal cord. identify more pluripotent stem cells, and isolation of
dividing precursors from more mature spinal cords
Introduction would likely isolate glial restricted precursors. Further,
since the transition from a dividing nestin1 multipotential
Pluripotent stem cells in the central nervous system may cell to a postmitotic neuron occurs over a short span
generate differentiated neurons and glia either directly of time in vivo (2±3 days), documenting a similar transi-
tion in vitro should be straightforward.or through the generation of lineage-restricted interme-
We have previously described methods to culturediate precursors (Temple and Raff, 1985; Price et al.,
E10.5 neuroepithelial (NEP) stem cells as undifferenti-1987; Williams et al., 1991; Reynolds and Weiss, 1992;
ated cells for extended periods in vitro and have furtherWalsh and Cepko, 1992; Price et al., 1992; Kilpatrick
shown that these populations were able to generate theand Bartlett, 1993; Kilpatrick and Bartlett, 1995; Reid et
three major cell types of the CNS (Kalyani et al., 1997).al., 1995; Reynolds and Weiss, 1996; Temple and Qian,
Thus, NEP cells represent a population of dividing multi-1996). In the developing retina, it appears that multipo-
potent stem cells that may differentiate into neuronstent retinal precursors can generate any combination of
either via intermediate neuroblasts or directly as partdifferentiated cells even at their final division, indicating
of their terminal differentiation. To determine whetherthat intermediate precursors do not exist (Turner and
neurons differentiate from NEP cells via intermediate,Cepko, 1987). In other regions of the central nervous
more restricted precursors, we have isolated and char-system, in contrast, retroviral labeling studies have sug-
acterized a variety of immunologically defined popula-gested the existence of lineage-restricted precursors
tions from the developing spinal cord and from differ-that generate only one cell type or a limited number of
entiating culturesof NEP cells (Rao and Mayer-Proschel,cell types (Price et al., 1987; Williams et al., 1991; Walsh
1997; Kalyani et al., 1997). In this paper, we show thatand Cepko, 1992). Intermediate stage precursors such
E-NCAM1 cells are present in E13.5 neural tube cultures
as the bipotential oligodendrocyte-type-2 astrocyte pre-
and that these cells are mitotic, selfrenewing stem cells
cursor (O-2A) and neuronal precursors have also been
that can generate multiple neuronal phenotypes but not
described in tissue culture studies (Temple and Raff, astrocytes or oligodendrocytes. Thus, neuronal-restricted
1985; Renfranz et al., 1991; Kilpatrick and Bartlett, 1993; precursors (NRPs) are an identifiable stage in the in vivo
Gao and Hatten, 1994; Ray and Gage, 1994; Hunter differentiation of neurons. We show further that cells
and Hatten, 1995; Kilpatrick and Bartlett, 1995). Yet, the morphologically and phenotypically identical to NRPs
generation of intermediate lineage-restricted precursors can be isolated from NEP cell cultures derived from
E10.5 spinal cords. Clonal analysis shows both that indi-
vidual NEP cells generate neurons via the generation of³ To whom correspondence should be addressed.
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neuronal precursors and that individual NEP cells can cytokines tested, optimum growth was seen when cells
generate neuronal-restricted and glial-restricted precur- were cultured in medium supplemented with fibroblast
sors. These data provide the first demonstration of a growth factor (FGF; 10 ng/ml) and neurotrophin-3 (NT-3;
direct lineal relationship between multipotent and neu- 10 ng/ml). In the presence of FGF/NT-3, most (.95%)
ronal-restricted stem cells and suggest that neural dif- E-NCAM1 cells divided in culture to generate colonies
ferentiation involves progressive restriction in develop- that could contain several hundred cells. Figures 3B±3D
mental fate. show the development of one such clone. By day 5,
most colonies (.95%) contained between 20±50 daugh-
Results ter cells that continued to express E-NCAM immunore-
activity (Figures 3D and 3E). Daughter cells appeared
E-NCAM Immunoreactive Cells Are Present in E13.5 phase bright and had short processes (Figures 3B±3D).
Neural Tubes and Are Neuronal-Restricted At this stage, most E-NCAM1 cells did not express b-III
Stem Cells tubulin or neurofilament-L immunoreactivity (data not
To determine if a dividing neuronal-restricted precursor shown).
is present in vivo, we analyzed sections of E13.5 spinal To promote differentiation of E-NCAM1 clones, the
cords using a panel of early neuronal markers (data not FGF/NT-3 medium was replaced with medium lacking
shown). Polysialated or embryonic NCAM (E-NCAM), FGF and containing retinoic acid (RA). In this differentia-
which is thought to play a critical role in early embryonic tion medium, E-NCAM1 cells stopped dividing, elabo-
development (Chuong and Edelman, 1984; Linneman rated extensive processes, and started to express addi-
and Bock, 1989), was a likely marker since it has been tional neuronal markers (see table in Figure 3). Quadruple
shown to be expressed in early neurogenesis (Chen labeling of clones with neuronal and glial markers and
and Chiu, 1992; Blass-Kampmann et al., 1994). E-NCAM bisbenzimide histochemistry to identify all cells showed
immunoreactivity was first detected at E13.5 (Figure 1). that all clones contained b-III tubulin1 cells (Figures 3F
E-NCAM immunoreactive cells were seen in the margins and 3G) and that none of the E-NCAM1 clones differenti-
of the neural tube but not in the proliferating ventricular ated into oligodendrocytes or astrocytes (Figures 3F
zone. Double labeling with an antibody to b-III tubulin and 3H). The neuronal character of E-NCAM1 cells was
indicated that most E-NCAM immunoreactive cells co- further confirmed by recording from randomly selected
expressed this neuronal marker. A small proportion of
E-NCAM1 cells. As can be seen in Figure 4, all (four
cells present more medially were E-NCAM1 but did not
of four) recorded cells showed electrical activity and
express b-III tubulin immunoreactivity, suggesting that
generated action potentials in response to a depolariz-
E-NCAM may be an early and specificmarker of differen-
ing stimulus.
tiation of neuronal precursors that is expressed prior to
Although the absence of A2B5 immunoreactivity and
b-III tubulin.
glial fibrillary acid (GFAP) immunoreactivity is a strongTo further characterize E-NCAM immunoreactive
indicator of theabsence of glialdifferentiation, we testedcells, E13.5 spinal cords were dissociated and E-NCAM-
differentiated E-NCAM1 clones with additional markersexpressing cells were double labeled with a panel of
of the oligodendrocyte lineage. Randomly selected clonesantibodies (Figures 2A±2F). E-NCAM immunoreactive
(5) were harvested and the cDNA analyzed for expres-cells constituted 60% 6 3% (average of three indepen-
sion of proteolipid protein (PLP, an oligodendrocytedent experiments) of all cells present in dissociated cul-
marker) and Map-2 kinase (a neuronal marker). All (fiveture 24 hr after plating. The majority of the remaining
of five) clones tested expressed Map-2 kinase but notcells were A2B51 (Eisenbarth et al., 1979). We have pre-
PLP (Figure 4A). In parallel, other E-NCAM1 clones (17)viously shown that at this stage, A2B5 immunoreactive
were processed for immunohistochemistry to show thatcells are glial precursor cells (Rao and Mayer-Proschel,
neither O4 nor Gal-C immunoreactivity was detectable1997). Consistent with our previous results, b-III tubulin
in differentiated E-NCAM1 clones (Figure 4B). To furtheror E-NCAM immunoreactive (1) cells did not coexpress
confirm that most E-NCAM1 clones had differentiatedA2B5 (Figures 2A and 10; data not shown). The vast
into neurons, some clones were labeled with Map-2majorityof cultured E-NCAM immunoreactive cells (85%6
kinase and neurofilament antibodies (Figures 4D and8%) coexpressed b-III tubulin immunoreactivity (Figures
4E, respectively). Virtually all E-NCAM1 cells expressed2C and 2D) and other neuronal markers (see Figure 2G
Map-2 kinase and neurofilament-M, demonstrating thatand table in Figure 2) as well as nestin immunoreactivity
E-NCAM1 cells are restricted in their differentiation po-(Figures 2E and 2F) but did not express markers charac-
tential.teristic of glial precursors (see table in Figure 2), consis-
The inability to detect oligodendrocyte and astrocytetent with the in vivo segregation of E-NCAM and glial
differentiation was unlikely to be due to the death ofprecursor immunoreactivity (Warf et al., 1991; Noll and
oligodendrocytes and astrocytes that might have differ-Miller, 1993; Pringle and Richardson, 1993; Pringle et
entiated from E-NCAM1 precursors, as A2B51 glial pre-al., 1996). Approximately 20% of the E-NCAM1 cells
cursorcells purified and grown in parallel in thepresencedivided in a 24 hr period (Figure 2B). Most of the dividing
of FGF and NT-3 continued to express A2B5 withoutE-NCAM1 cells did not coexpress b-III tubulin (data not
apparent cell death (Figures 5C and 5D) and generatedshown), indicating that this population of cells could
healthy oligodendrocytes and astrocytes after 10 daysrepresent a dividing neuroblast.
in culture (data not shown; Fok-Seang and Miller, 1994;To determine the differentiation potential of E-NCAM1
Rao and Mayer-Proschel, 1997). In addition, A2B51 cellscells, the E-NCAM1 population was purified by immuno-
never generated neurons in the presence of FGF/NT3panning (Figure 3A) and plated at clonal density in grid-
ded dishes (see Experimental Procedures). Of all the and showed no expression of E-NCAM at any time
Neuroblasts in the Spinal Cord
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Figure 1. E-NCAM Immunoreactivity Is Spa-
tially Restricted atE13.5 to Regions of Neuron
Generation
E13.5 fresh frozen embryos were sectioned
and double labeled with antibodies against
E-NCAM (red) and b-III tubulin (green) (A) or
stained with E-NCAM (red) and counter-
stained with bisbenzimide (blue), a nuclear
marker to identify all cells (B). Note that
E-NCAM immunoreactivity is seen in cells mi-
grating from the ventricular zone and in a dor-
soventralgradient in the margins of the devel-
oping neural tube. Double labeling in (A)
shows that most E-NCAM immunoreactive
cells also express b-III tubulin.
tested (Figures 5A and 5B). Thus E-NCAM immunoreac- promotes astrocyte differentiation of both spinal cord
NEP cellsand A2B5 immunoreactive glial precursor cellstive cells, unlike A2B5 immunoreactive glial-restricted
precursors, could not differentiate into oligodendro- (Rao and Mayer-Proschel, 1997; Kalyani et al., 1997). All
(24 of 24) E-NCAM1 clones that were grown in neuronal-cytes or astrocytes and appeared limited to neuronal
differentiation when compared to multipotential E10.5 promoting medium contained only b-III tubulin1 cells
after 8 days, as described previously, while the clonesneuroepithelial cells.
While we have clearly shown that in our system, grown in serum-containing medium did not generate
astrocytes or proliferate. From a total of 97 E-NCAM1E-NCAM identifies neuronal-restricted precursor cells,
it has been reported that certain glial precursors at later clones grown in glial-promoting conditions, 90 clones
(92%) consisted of a single dead cell after 24 hr, whilestages in development can also express E-NCAM immu-
noreactivity (Blass-Kampmann et al., 1994). We and oth- the remaining 7 clones (8%) contained one or two dead
cells after 48 hr. Thus, E-NCAM immunoreactive cells,ers (e.g., Chen and Chiu, 1992) have not seen E-NCAM1/
GFAP1 cells in the developing spinal cord either in vivo in contrast with glial precursor cells, fail to proliferate
or differentiate into astrocytes.or in vitro. This observation nevertheless raises the pos-
sibility that some E-NCAM1 cells we have identified as Since most E-NCAM1 cells died when plated in
astrocytic conditions, we further tested the ability ofneuronal precursors may be bipotential. To test this
possibility, we plated E-NCAM1 cells, clonally, in either E-NCAM1 to differentiate into astrocytes by growing
them in a nonserum-containing medium that promotesneuronal-promoting medium (FGF/NT-3) or in glial-pro-
moting medium (FGF/10% FCS) and compared their de- astrocyte differentiation (NEP medium supplemented
with FGF and ciliary neuronotrophic factor [CNTF]). Asvelopment. Medium containing FGF with 10% FCS was
chosen to test for glial differentiation, as this medium is seen in Figure 6, no E-NCAM1 clone generated GFAP
Neuron
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Figure 2. E13.5 E-NCAM Immunoreactive Cells
Express Neuronal but Not Glial Markers
Spinal cords from E13.5 embryos were dis-
sected and acutely dissociated, and cells
were plated on poly-L-lysine/laminin and
stained after 24 hr with A2B5 (A) or antibodies
against E-NCAM ([B], [C], and[E]), b-III tubulin
([A] and [D]), bromo-D-oxy-uridine (BrDU) (B),
and nestin (F). Panel (A) shows that b-III
tubulin (red) immunoreactive cells do not
express A2B5 (green). Panel (B) shows cul-
tures double labeled with antibodies against
E-NCAM (green) and BrDU (red). Some dou-
ble positive cells are indicated by arrows.
Panels (C) and (D) show double-labeled cells
that coexpress E-NCAM (red, [C]) and b-III
tubulin (green, [D]), respectively. Note that
most E-NCAM immunoreactive cells also ex-
press b-III tubulin immunoreactivity. Panels
(E) and (F) are double labeled for E-NCAM
(red, [E]) and nestin (green, [F]). Note that
most E-NCAM immunoreactive cells coex-
press nestin. Panel (G) shows that the panned
E-NCAM population have detectable mes-
sage for Map-2 kinase and neurofilament-M,
two additional neuronal markers. The table
summarizes the antigenic profile of the cells,
showing that E-NCAM1 cells from E13.5 spi-
nal cord expressneuronal but not glial markers.
immunoreactive cells in this condition. In contrast, of prolonged self renewal and can generate multiple
daughter cells capable of generating neurons.E-NCAM2 cells grown in parallel readily differentiated
into GFAP immunoreactive cells, further confirming that This suggests that E-NCAM immunoreactivity identi-
fies a neuroblast cell that can differentiate into multipleE-NCAM1 cells are restricted in their differentiation po-
tential. neuronal phenotypes in culture, even after multiple pas-
sages. NT-3 and FGF are required to maintain the blast
cell in a proliferative state, while RA promotes differenti-E-NCAM1 Cells Are Able to Self Renew without
Losing Their Differentiation Potential ation.
Primary clones of E-NCAM1 cells grown in FGF and
NT-3 grew to large sizes of several hundred cells after E10.5 NEP Cells are E-NCAM Negative Both In Vitro
and In Vivo and Differentiate to Generate7±10 days in culture, indicating some degree of self
renewal. To demonstrate prolonged self renewal of the E-NCAM1 Neuronal-Restricted
Precursors In VitroE-NCAM1 population, selected clones were followed by
secondary and tertiary subcloning. The table in Figure We have previously shown that individual NEP cells de-
rived from embryonic day 10.5 spinal cord are an E-NCAM7 shows that all clones examined generated numerous
daughter clones, which subsequently generated tertiary immunonegative, multipotent, self-renewing population
of cells that can generate neurons, astrocytes, and oligo-clones. Small clones and very large clones showed simi-
lar self renewal potential. When tertiary clones were dendrocytes (Kalyani et al., 1997). To determine if neu-
ronal differentiation from NEP precursors involved theswitched to a medium containing RA and lacking FGF,
the majority of cells in a clone differentiated into postmi- generation of an E-NCAM1 intermediate neuronal pre-
cursor cell, we examined NEP cell cultures that weretotic neurons shown as cells expressing b-III tubulin
(Figures 7A and 7B). Thus, E-NCAM1 cells are capable induced to differentiate in vitro for the presence of
Neuroblasts in the Spinal Cord
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E-NCAM1 immunoreactive cells. As can be seen in Fig-
ure 8, induced NEP cultures consist of multiple pheno-
types, including E-NCAM1 cells. Like the E13.5 E-NCAM1
cells, NEP-derived E-NCAM1 cells did not express glial
markers (Figure 8A) but coexpressed b-III tubulin (20%±
30%) and nestin (70%±80%) immunoreactivity (data not
shown and Figure 8B, respectively). Ninety percent of
panned E-NCAM1 cells incorporated BrdU in culture
(Figure 7C) and generated neurons after addition of RA
or NT-3 and thus appeared similar to the E13.5 E-NCAM
immunoreactive cells. Thus E-NCAM2 NEP cells differ-
entiate into E-NCAM1 cells under appropriate differenti-
ation signals.
To determine whether single E-NCAM1 cells that were
generated from E-NCAM2 NEP cells were also restricted
to neuronal differentiation, NEP-derived E-NCAM1 cells
were studied in clonal culture. NEP cells (E-NCAM2)
were induced to differentiate by replating on laminin
lacking chick embryo extract as previously described
(Kalyani et al., 1997). Forty-eight hours after cells were
allowed to differentiate, 10%±30% of the cells had be-
gun to express E-NCAM immunoreactivity. NEP-derived
E-NCAM1 cells were selected by immunopanning, indi-
vidual E-NCAM1 cells were plated in medium containing
FGF/NT3, and clones were analyzed after 10 days. All
clones contained E-NCAM1/b-III tubulin1 cells (Figure
9) but not GFAP or A2B5 immunoreactive cells (data not
shown). In addition, individual E-NCAM1 cells failed to
differentiate into oligodendrocytes or astrocytes under
culture conditions that promoted astrocytic and oligo-
dendroglial differentiation from the parent NEP cell pop-
ulation (data not shown). E-NCAM1 cells could be main-
tained as dividing precursor cells in defined medium in
the presence of high concentrations of FGF (10 ng/ml)
and NT-3 (10 ng/ml). E-NCAM1 cells maintained for up
to 3 months could readily differentiate into b-III tubulin1
mature neurons that expressed a variety of neurotrans-
mitter phenotypes when exposed to RA and grown on
laminin. Thus, NEP-derived E-NCAM1 cells are similar
to E13.5 neuronal precursors in their differentiation po-
tential, in their antigenic profile, and in the conditions
optimal for extended growth as a dividing precursor cell
population.
E-NCAM Immunoreactive Cells Are Generated
from a Common Neuroglial NEP
Progenitor Cell
Differentiation of the E-NCAM1 population from an ap-
parently homogeneous nestin1/E-NCAM2 NEP cell pop-
ulation suggests a progressive restriction in develop-
Figure 3. E13.5 E-NCAM Immunoreactive Cells Are Neuronal- mental fate. It is, however, possible (although unlikely)
Restricted Precursors
that individual E-NCAM2 NEP cells are precommitted
(A) E-NCAM1 cells from E13.5 embryos were purified using immuno- to generating neuroblasts or glioblasts. To rule out this
panning and stained 24 hr after panning with the E-NCAM-specific
possibility, we examined individual NEP (E-NCAM2)antibody. Greater than 95% of the cells were E-NCAM1 (see Results)
at that time. Purified and stained cells were plated on gridded clonal
dishes and individual E-NCAM1 cells were identified and followed
over time.
Panels (B) (day 1), (C) (day 3), and (D) (day 5) are representative and withdrawal of FGF and quadruple labeled with bisbenzimide
pictures of an E-NCAM immunoreactive clone at different stages of (blue, [G] and [H]) and antibodies to A2B5 (green, [H]), GFAP (green,
development. [H]), and b-III tubulin (red, [G]). Note that all cells are b-III tubulin1
(E) The same clone stained with the E-NCAM antibody (green). Note (compare [F] and [H]), and no GFAP or A2B5 immunoreactive cells
that all cells appear E-NCAM immunolabeled. are present. The table summarizes the results obtained with all
(F±H) A phase picture and staining of a representative clone that quadruple-labeled clones followed in culture from three indepen-
was induced to differentiate into postmitotic cells by addition of RA dent experiments.
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Figure 4. E-NCAM Immunoreactive Clones
Express Multiple Neuronal Markers on Differ-
entiation
E-NCAM1 cells from E13.5 embryos were
plated clonally, and individual E-NCAM1 cells
were identified and followed over time. After
5 days in culture, cells were induced to differ-
entiate into postmitotic cells by addition of
RA and withdrawal of FGF. Some clones were
harvested, and cDNA was isolated and tested
for the expression of Map-2 kinase and PLP.
Panel (A) shows the results from one rep-
resentative clone. Note the expression of
Map-2 kinase and the absence of PLP and
DM20 expression. In contrast, PLP and DM20
are readily detected in A2B5 oligodendrocyte
precursor cells grown identically. Sister clones
and mixed E13.5 cultures grown in parallel
were also labeled with E-NCAM (green, [B]
and [C]) and antibodies to O4 and Gal-C (red,
[B] and [C]). Note that no E-NCAM1 clone
contained O4/Gal-C immunoreactive cells. In
contrast, in mixed E13.5 cultures, Gal-C/O4
immunoreactive cells are readily detectable.
Note also that E-NCAM immunoreactivity is
not detected on O4/Gal-C immunoreactive
cells. Other E-NCAM1 clones were stained
with bisbenzimide (blue, [D] and [E]) and either
Map-2 kinase (red, [D]) or neurofilament-M (red,
[E]). Note that while no NCAM1 clones ex-
pressed detectable O4 and Gal-C immunore-
activity (B), virtually all E-NCAM1 cells are
positive for neuron-specific markers Map-2
kinase and neurofilament-M (compare [D]and
[E]). Electrophysiological recordings were also
obtained from randomly selected E-NCAM1
cells. Panel (F) shows the current responses
of a representative cell to a series of voltage
commands evoked from a holding potential
of 280 mV. Note the presence of a transient inward current followed by fast and slow outward currents in response to depolarizing voltage
command. Panel (G) shows action potentials from two representative cells elicited by releasing neurons from a 2180 pA current injection
used to set Vm to 280.
clones for theirability to generate E-NCAM immunoreac- To test if most neurons were generated via an
E-NCAM1 intermediate neuroblast, we utilized comple-tive cells and A2B5 immunoreactive cells. A2B5 and
E-NCAM were chosen since we and others have pre- ment-mediated cell lysis to selectively kill E-NCAM1
cells. Twenty-four hours after replating NEP cells in dif-viously shown that A2B5 immunoreactivity is unique to
oligodendrocyte-astrocyte precursors at this stage of ferentiating conditions, E-NCAM immunoreactive cells
were killed using an IgMantibody toE-NCAM and guineadevelopment (Warf et al., 1991; Fok-Seang and Miller,
1992, 1994; Pringle et al., 1996; Rao and Mayer-Pros- pig complement (see Experimental Procedures). In sister
plates, glial precursors were killed using an anti-A2B5chel, 1997; Kalyani et al., 1997). NEP cells were plated
in clonal culture as previously described (Kalyani et al., IgM antibody and complement. At this stage in develop-
ment, most E-NCAM1 cells do not express b-III tubulin1997), and their development was followed for 7 days.
Of 112 NEP clones that were followed in culture, 83% (unpublished data). Treated plates were allowed to
differentiate for an additional 3 days, and the develop-of the clones contained both A2B5 and E-NCAM immu-
noreactive cells (Figure 10). Five percent of the clones ment of neurons was monitored. E-NCAM-mediated
lysis significantly reduced the number of b-III tubulinconsisted of A2B5 immunoreactive but not E-NCAM im-
munoreactive cells, and 12% of the clones showed no immunoreactive cells that developed when compared
to cultures treated with A2B5 (219 6 35 versus 879 6 63,convincing staining for either A2B5 or E-NCAM immuno-
reactivity. In all clones tested, E-NCAM and A2B5 were respectively; mean of two independent experiments),
suggesting that neuronal differentiation from NEP cellsexpressed in nonoverlapping populations. The ability of
the E-NCAM1 and A2B51 cells to generate neurons and/ in vitro requires a transition through an E-NCAM immu-
noreactive state.or glial cells was tested by selecting cells from individual
clones and monitoring their development (data not
shown; see also Rao and Mayer-Proschel, 1997). Thus, Discussion
the vast majority of NEP cells appear to be capable of
generating precursors for glial-restricted cells as well Several models for neuronal differentiation in mammals
have been proposed (reviewed by Temple and Qian,as neuronal-restricted precursors.
Neuroblasts in the Spinal Cord
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Figure 5. Glial Precursor Cells Grow in Neuronal-Promoting Conditions
Immunopanned A2B51 cells derived from dissociated E13.5 spinal cords were cultured in neuronal-promoting medium (basal medium plus
FGF/NT-3). Cultures were grown for 5 days and then switched to RA-containing medium as described in the Experimental Procedures, and
sister plates were stained for either E-NCAM ([A] and [B]) or A2B5 ([C] and [D]). Note that no A2B5 immunopanned cell expressed E-NCAM
immunoreactivity when grown in neuronal conditions (compare [A] and [B]). In contrast, all A2B5 immunopanned cells continued to express
A2B5 immunoreactivity (compare [C] and [D]), indicating that neuronal-promoting conditions do not affect the survival and proliferation of
glial precursor cells.
1996; McKay, 1997; Stemple and Mahanthappa, 1997; cell culture studies have suggested a common neuro-
oligo precursor and a neuro-astrocyte precursor (SanesMorrison et al., 1997). Our results provide direct evi-
dence to support a model describing initially multipotent et al., 1986; Price et al., 1987, 1992; Sanes, 1989; Williams
et al., 1991; Lois and Alvarez-Buylla, 1993;Williams, 1995).cells undergoing progressive restriction in develop-
mental potential. We have provided evidence that ini- Such precursors may very well exist unrecognized in
induced NEP cultures because of the absence of distin-tially multipotent NEP cells generate neuronal-restricted
precursors in vitro and that such neuronal-restricted guishing markers. Our present results do not argue for
or against the existence of other classes of intermediateprecursors (NRPs) are also present in vivo. We have
shown that NRPs fulfill the criteria of blast cells and that precursors.
Our results do argue, however, that E-NCAM immuno-a direct lineal relationship between multipotent stem
cells and more restricted NEP cells exists. While the reactive cells, either differentiated in vitro from E10.5
spinal cord or derived directly from E13.5 spinal cord,existence of neuronal-restricted stem cells has been
proposed (Ray and Gage, 1994; Temple and Davis, 1994; are restricted in their developmental potential. E-NCAM
cells readily differentiate into neurons but fail to dif-reviewed by Morrison et al., 1997), this represents a
direct demonstration of a transition from a multipotent ferentiate into oligodendrocytes or astrocytes under all
culture conditions tested. We have, therefore, calledto a more restricted neuronal stem cell in the nervous
system. E-NCAM immunoreactive cells neuronal-restricted pre-
cursors or NRPs. We have seen occasional a-GFAP1Additional results from our laboratories suggest that
A2B5 immunoreactive glial precursors also arise from cells present in the largest clones (,1% of the total
clones analyzed) after repeated subcloning over 3NEP cells (Rao and Mayer-Proschel, 1997). Thus, at least
two types of intermediate precursors exist. In principle, weeks (unpublished data). We have never, however,
seen astrocytes in primary or secondary clones (seejust these two classes of intermediate precursors would
be sufficient to generate all major types of cells in the Results). The GFAP1 cells likely represent a contaminat-
ing population carried through repeated subcloning. Al-CNS. We believe, however, that the cells we have char-
acterized are unlikely to represent all classes of interme- ternatively, some E-NCAM1 cells may be bipotential
(Blass-Kampmann et al., 1994), or the ability to generatediate precursors. Retroviral lineage studies as well as
Neuron
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Figure 6. E-NCAM Immunoreactive Cells Do Not Differentiate into
Astrocytes
E-NCAM1 and E-NCAM2 cells from E13.5 rat spinal cords were
separated by immunopanning (see Experimental Procedures) and
plated in clonal culture in medium containing FGF and CNTF. Cells
were allowed to grow in this glial condition for 10 days. Cultures
were then fixed and double labeled with antibodies to E-NCAM (red)
and GFAP (green). The table in (A) summarizes the results from one
such clonal experiment, while (B) and (C) show one representative
clone of E-NCAM1 and E-NCAM2 cells. Note that no E-NCAM immu-
noreactive clone contained GFAP immunoreactive cells. In contrast,
E-NCAM2 cells readily differentiated into GFAP1 astrocytes under
these conditions. Note also that no GFAP1 cell expressed E-NCAM
immunoreactivity.
astrocytes may be a property acquired through precur-
sor maturation (Smith-Thomas et al., 1990; Pixley, 1992;
Kilpatrick et al., 1993; Mehler et al., 1995; Gross et al.,
1996) in vitro. Proving or disproving these alternatives
is difficult, given our limited knowledge of the molecular
events underlying neuroglial interactions. In any case,
the E-NCAM1 cells are clearly distinct from NEP cells
and A2B5 glial precursor cells in their relative inability
to differentiate into astrocytes.
We have clearly demonstrated that multipotent stem
cells exist and can generate restricted self-renewing
precursors and that such restricted precursors are also
generated during normal development. Further, our
complement killing experiments with E10.5 NEP cells
Figure 7. E-NCAM Immunoreactive Cells Undergo Self Renewal
and our analysis of E13.5 E-NCAM immunoreactive
Individual E-NCAM1 cells from E13.5 embryonic spinal cord wereclones suggest that the majority of stem cells differenti-
plated in fibronectin/laminin and expanded for 7 days in the pres-
ating into neurons do so by passing through an E-NCAM ence of FGF/NT-3. Five individual clones were randomly selected
immunoreactive phase in vivo and in vitro. A small frac- and replated at clonal density using the same expansion conditions.
The number of secondary clones was counted, and large clonestion of stem cells may also be able to differentiate into
were selected and replated. The number of tertiary clones obtainedneurons without going through an intermediate precur-
was counted, and clones were then induced to differentiate intosor stage. Such maturation has been described in the
postmitotic neurons by replacing FGF with RA. The lower panelcortex (Davis and Temple, 1994; Temple and Davis,
shows a representative illustration of a tertiary clone induced to
1994). In these experiments, the authors showed that the differentiate and stained with an antibody against b-III tubulin. Pan-
majority of dissociated E14.5 cortical cells differentiated els (A) and (B) are phase contrast and fluorescent images, respec-
tively.into single cell clones of neurons, suggesting that a
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Figure 8. NEP-Derived E-NCAM Immunore-
active Cells Express Neuronal but Not Glial
Markers
NEP cells derived from E10.5 embryos were
expanded in the presence of FGF and CEE
for 5 days and differentiated by replating on
laminin in the absence of CEE. In (A), differ-
entiating NEP cells were triple labeled with
antibodies to E-NCAM1 (green), GFAP (Blue),
and Gal-C (red) to show that E-NCAM immu-
noreactive cells that differentiate from NEP
cells do not express astrocytic (GFAP) or oli-
godendrocytic (Gal-C) markers. In (B), a sister
plate was double labeled with antibodies to
E-NCAM1 (green) and nestin (red) to show
that NEP-derived E-NCAM immunoreactive
cells coexpress nestin (see arrows). In (C),
differentiating NEP cells were incubated for
24 hr with BrDU and subsequently double-
labeled with an antibodyagainst BrDU (green)
and E-NCAM (red). Note that most E-NCAM
immunoreactive cells have divided in 24 hr.
The table summarizes the antigenic profile of
E-NCAM1 cells derived from E10.5 NEP cells.
Note that NEP-derived E-NCAM1 cells are an-
tigenically similar to E13.5 E-NCAM1 cells
and, like E13.5 E-NCAM1, do not express any
of the glial markers examined.
stem cell matured into a neuron without an intermediate in the spinal cord, and the issue of what are progenitors
of SVZ cells needs to be clarified. Direct comparisonsprecursor stage of differentiation. Rigorous demonstra-
tion of the multipotentiality of stem cells that differenti- of SVZ cells with E-NCAM1 neuroblasts will reveal the
relationship between these cells, the SVZ, and otherated into neurons without cell division, however, was not
possible, since unambiguous markers for multipotential spinal cord neuronal precursors.
The cytokine dependence of the E-NCAM neuroblaststem cells were unavailable. It is also possible that the
mode of differentiation of stem cells may depend on precursor, its restricted differentiation potential, and its
self renewal capabilities are similar to those of the spinalenvironmental cues (reviewed by Morrison et al., 1997).
A multipotential stem cell may not always differentiate cord neuroblast precursor isolated by Ray and Gage
(1994). In their mass culture experiments, the authorsinto a neuron via an intermediate precursor cell. It may,
under different culture conditions, mature into a neuron were unable to prove that the neuroblast cell does not
generate astrocytes. We have obtained results that con-without undergoing any rounds of division. While we
cannot completely exclude the existence of alternate firm and extend their observations. By identifying a cell
surface epitope (E-NCAM) that can be used to isolatemodels of differentiation, our data provide compelling
evidence that intermediate precursors are lineally re- the precursors and using clonal analysis to demonstrate
a restriction to neuronal differentiation, we have shownlated to and arise from multipotent precursors, and they
also suggest that differentiation of at least some stem that individual E-NCAM immunoreactive cells are neu-
ronal-restricted precursor cells. More importantly, wecells in the CNS involves a progressive restriction in
developmental potential. demonstrate that theneuroblast precursor differentiates
from an earlier, less restricted precursor.We have also demonstrated that E-NCAM1 cells pres-
ent in vivo at E13.5 are neuronal-restricted precursors. Our immunopanning and double labeling datademon-
strate that E-NCAM can be used to identify a specificImmunocytochemical labeling with E-NCAM suggests
that E-NCAM1 cells are not present in the ventricular neuronal sublineage that is generated from multipoten-
tial NEP cells. Like markers for intermediate precursorszone but can be detected in cells migrating away from
the ventricular zone, suggesting that these cells may be in the hematopoietic system and neural crest, however,
E-NCAM (and the A2B5 glial precursor marker as well)identical to the SVZ precursor cells that proliferate and
migrate to the olfactory bulb (reviewed by Temple and are not unique to intermediate precursors. E-NCAM has
been shown to label some astrocytes (Blass-KampmannQian, 1996). The ability to self renew and divide to form
large clones of precursor cells further supports this hy- et al., 1994). Similarly, A2B5 has been shown to recog-
nize neurons in some species (Eisenbarth et al., 1979;pothesis. However, no SVZ equivalent has been identified
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Figure 9. NEP-Derived E-NCAM Immunoreactive Cells Are Neu- Figure 10. NEP-Derived E-NCAM Immunoreactive Cells Arise from
ronal-Restricted Precursor Cells Mixed Clones that Contain Other Restricted Precursors
NEP cells derived from E10.5 embryos were expanded in the pres- NEP cells derived from E10.5 embryos were expanded in the pres-
ence of FGF and CEE for 5 days and differentiated by replating on ence of FGF and CEE for 5 days, harvested by trypsinization and
laminin in the absence of CEE. Immunopanned E-NCAM1 cells were replated at clonal density in gridded clonal dishes. After 7 days in
then plated on gridded clonal dishescoated with fibronectin/laminin, culture, individual clones were double labeled with antibodies
and single cells were followed in culture. After 5 days, clones were against E-NCAM and A2B5 as described in the Experimental Proce-
switched to RA and FGF was withdrawn. Clones were allowed to dures. The upper panel shows one such NEP clone that contained
grow for an additional 3 days, fixed with paraformaldehyde, and both E-NCAM (red) and A2B5 (green) immunoreactive cells. Note
triple labeled with A2B5 and antibodies against GFAP and b-III tu- that no cell coexpressed both markers. The lower panel summarizes
bulin. In addition, cells were counterstained with bisbenzimide to the results of the staining of all clones studied.
show individual cell nuclei. The upper panel shows a representative
clone comprised entirely of b-III immunoreactive cells. The lower
panel summarizes the results of the staining of all clones studied. In summary, we have shown that E-NCAM immunore-
Note that no clone contained astrocytes (GFAP1 cells) or glial pre-
activity identifies a self-renewing neuronal-restrictedcursor cells (A2B51 cells).
precursor cell (NRP), present at E13.5, that has lost the
ability to generate astrocytes or oligodendrocytes but
retains the ability to generate multiple neuronal pheno-Girdlestone and Weston, 1985; Goldman, 1990; Satoh
and Kim, 1995) and is transiently expressed by astro- types. NRPs are lineally related to and arise from multi-
potent NEP stem cells. Both neuronal-restricted andcytes in some culture conditions (Lillien and Raff, 1990;
Lillien et al., 1990). Nevertheless, under the specific cul- glial-restricted precursors can arise from a common
multipotent stem cell, suggesting a sibling relationshipture conditions defined above, these markers may be
used to select intermediate precursors and therefore between these two classes of precursors. Our results
provide a culture model for in vivo differentiation that isrepresent the first cell surface epitopes that are coex-
pressed in concordance with a restriction in develop- amenable to perturbation, allowing the process of neural
lineage restriction and differentiation to be character-mental potential. Analysis in other species will reveal
whether these markers will serve equally well in identi- ized in detail. Further, our results show that E-NCAM
can be used for selectively sorting and amplifying NRPsfying intermediate precursors in other species.
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allowed to settle for 4 hr; single cells were identified, and theirthrough serialpassages for gene expression studiesand
development was followed in culture. NEP cells were grown in NEPtherapeutic use.
medium as described above, and neuroblasts were grown in NEP
medium with the addition of NT-3 (20 ng/ml) and the withdrawal of
Experimental Procedures
CEE. In most experiments, clonal cultures were terminated after 12
days. In these assays, z10%±20% of single cells died within 24 hr.
Substrate Preparation
Clonal plates were usually triple labeled with the cell surface antigen
Laminin, used at a concentration of 20 mg/ml (Biomedical Technolo-
and the appropriate secondary antibodies.
gies), was dissolved in distilled water and applied to tissue culture
plates (Falcon). For the fibronectin solution, fibronectin (Sigma) was
Immunopanning of E-NCAM1 Cellsresuspended to a stock concentration of 10 mg/ml, stored at 2808C
NEP cells were cultured in 2CEE conditions for 6 days, and theand diluted to a concentration of 250 mg/ml in Dulbecco's phos-
E-NCAM1 cell population was purified using a specific antibody-phate-beffered saline (DPBS; Gibco). The fibronectin solution was
capture assay (Wysocki and Sato, 1978) with modification. In brief,applied to tissue culture dishes and immediately withdrawn. Subse-
cells were trypsinized and the suspension was plated on an A2B5quently, the laminin solution was applied, and the plates were incu-
antibody-coated dish (Eisenbarth et al., 1979) to allow binding of allbated for 5 hr. Excess laminin was withdrawn, and the plates were
A2B51 cells to the plate. The supernatant was removed, and theallowed to air dry. Plates were rinsed with water and then allowed
plate was washed with DMEM supplemented with additives de-to dry again.
scribed by Bottenstein and Sato (1979; DMEM-BS). The supernatant
was then plated on an E-NCAM antibody-coated dish to allow bind-Neuroepithelial Cell Cultures
ing of the E-NCAM immunoreactive cells. The bound cells wereSprague-Dawley rat embryos were removed at embryonic day 10.5
scraped off and plated on fibronectin/laminin-coated glass cov-or 13.5 and placed in a petri dish containing Hanks' balanced salt
erslips in 300 ml of DMEM-BS 6 growth factors at 5000 cells/well.solution (HBSS; Gibco). The trunk segments of the embryos (last
The A2B5 and E-NCAM antibody for coating the plates was usedten somites) were dissected using tungsten needles, rinsed, and
at a concentration of 5 mg/ml. Cells were allowed to bind to thethen transferred to fresh HBSS. Trunk segments were incubated at
plate for 20±30 min in a 378C incubator. Growth factors were added48C in 1% trypsin solution (Gibco) for 10±12 min. The trypsin solution
every other day at a concentration of 10 ng/ml. Recombinant bFGFwas replaced with fresh HBSS containing 10% fetal bovine serum
and NT3 were purchased from PeproTech, and retinoic acid (RA)(FBS). The segments were gently triturated with a Pasteur pipette
was obtained from Sigma.to release neural tubes from surrounding somites and connective
tissue. Isolated neural tubes were transferred to a 0.05% trypsin/
Gene Detection by RT-PCREDTA solution (Gibco) and incubated for 10 min. Cells were dissoci-
RNA Isolationated by trituration and plated in 35 mm dishes (Nunc) at high density.
Total RNA was isolated from cells or whole tissues by a modificationCells were maintained at 378C in 5% CO2/95% O2. Cells were re-
of the guanidine isothiocyanate-phenol-chloroform extraction methodplated at low density after 3 days. Cells from several dishes were
(TRIZOL, Gibco-BRL, Burlington, Ontario, Canada).then harvested by trypsinization (0.05% trypsin/EDTA solution for
cDNA Synthesis2 min), pelleted, resuspended in a small volume, and replated at a
cDNA was synthesized using 1±5 mg of total RNA in a 20 ml reaction.density of 5000 cells/35 mm dish. The basal medium used in all
Superscript II (Gibco-BRL), a modified Maloney murine leukemiaexperiments was a chemically defined medium modified from that
virus RT, and Oligo (dT)12±18 primers were used according to thedescribed by Stemple et al. (1988). The medium consisted of DMEM-
manufacturer's (Gibco-BRL) protocols.F12 (Gibco) supplemented with additives described by Bottenstein
PCRand Sato (1979), bFGF (20 ng/ml), and chick embryo extract (CEE;
Aliquots of cDNA, equivalent to 1/20 of the above reaction, were10%), prepared as described previously (Stemple and Anderson,
used in a 50 ml reaction volume. PCR amplification of different genes1992).
was performed using Elongase polymerase (Gibco-BRL). Primer se-
quences and cycling temperatures were optimized using wholeGeneration of Neurons, Oligodendrocytes, and Astrocytes
brain cDNA, and initial amplification products were sequenced toNeuroepithelial cells cultured in nondifferentiating conditions for 5
confirm the specificity of the amplification product. Unless other-days were harvested by trypsinization and replated onto dishes
wise specified, PCR reactions were run for 35 cycles (948C for 1sequentially coated with fibronectin/laminin (0.25 mg/ml) in neuro-
min, 568C for 1 min, and 688C for 1 min). A 10 min incubation atepithelial culture medium. For neuronal and oligodendrocyte differ-
728C was added at the end to ensure complete extension. The PCRentiation, the medium consisted of neuroepithelial culture medium
products werepurified using the Advantage PCR-Pure Kit (Clontech,described above with the omission of 10% CEE (2CEE condition).
Palo Alto, CA) and used for sequence analysis, restriction enzymeFor astrocyte differentiation, the 2CEE medium was supplemented
digest reactions, subcloning, and slot blot experiments as describedwith 10% fetal calf serum. Differentiation was assayed 5 or 9 days
in the results.after replating (as detailed in the Results).
For differentiation of neuroblast cells, FGF was withdrawn, and
retinoic acid (RA; Sigma) was added. Differentiation was assessed Immunocytochemistry
Staining procedures were performed as described previously (Rao48 hr after changing the medium.
and Mayer-Proschel, 1997). Staining for the cell surface markers
E-NCAM, A2B5, and Gal-C (cell lines obtained from ATCC) wasCultures of Neuronal-Restricted Precursor Cells
Sprague-Dawley rat embryos were removed at E13.5 and placed in carried out in cultures of living cells. To stain cells with antibodies
against the internal antigen GFAP (Sigma), which specifically recog-a petri dish containing Hanks' balanced salt solution (HBSS; Gibco).
The trunk segments of the embryos were dissected using tungsten nizes astrocytes (Bignami et al., 1972); b-III tubulin (GIBCO), which
stain neurons; nestin (DSHB), a marker for undifferentiated stemneedles, rinsed, and then transferred to fresh HBSS. Spinal cords
were mechanically dissected from the surrounding connective tis- cells (Lendahl et al., 1990); or 5-bromodeoxyuridine (BrdU; Sigma),
to determine the number of dividing cells, cultures were fixed withsue using sharpened No 5 forceps. Isolated spinal cords were incu-
bated in 0.05% trypsin solution for twenty min. The trypsin solution ice-cold methanol. All secondary monoclonal antibodies were pur-
chased from Southern Biotechnology.was replaced with fresh HBSS containing 10% fetal bovine serum
(FBS). The segments were gently triturated with a Pasteur pipette Double and triple labeling experiments were performed by simul-
taneously incubating cells in appropriate combinations of primaryto dissociate cells. Cells dissociated by trituration were plated in
35 mm dishes (Nunc) at high density. antibodies, followed by incubation with non-crossreactive second-
ary antibodies. In triple label experiments, cultures were incubated
with the primary antibody in blocking buffer for 1 hr, rinsed withClonal Cultures of Neuroepithelial Cells and Neuroblasts
Either panned cells or immunostained cells were trypsinized and buffer (PBS), and incubated with a species-specific secondary anti-
body in blocking buffer for 1 hr. Cultures were rinsed three timesplated in gridded clonal culture dishes (GreinerLabortechnik) coated
with fibronectin/laminin at a dilution of 100 cells/dish. Cells were with PBS and examined under a fluorescent microscope.
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Bisbenzimide histochemistry was performed as described pre- Gao, W.Q., and Hatten, M.E. (1994). Immortalizating oncogenes sub-
vert the establishment of granule cell identity in developing cerebel-viously. Bisbenzimide staining was generally done after double or
lum. Development 120, 1059±1070.triple labeling had been completed. Care was taken to ensure that
coumarin secondary (blue) was used with an antigen that was likely Girdlestone, J., and Weston, J.A. (1985). Identification of early neu-
to be negative in the assay, thus allowing quadruple labeling with ronal subpopulations in avian neural crest cell cultures. Dev. Biol.
three fluorescent channels. 109, 274±287.
For labeling with A2B5 and E-NCAM (both mouse IgM subtypes), Goldman, S.A. (1990). Neuronal development and migration in ex-
two independent methods were employed. Either purified A2B5 anti- plant cultures of the adult canary forebrain. J. Neurosci. 10, 2931±
body was directly coupled to fluorescein, as per the manufacturers' 2939.
protocols (Molecular Probes, Eugene, OR), or A2B5 was combined
Gross, R.E., Mehler, M.F., Mabie, P.C., Zang, Z., Santschi, L., andwith a secondary in solution before it was added to the cultured
Kessler, J.A. (1996). Bone morphogenetic proteins promote astro-cells. In both cases, staining with E-NCAM and an appropriate sec-
glial lineage commitment by mammalian subventricular zone pro-ondary was completed before staining with A2B5.
genitor cells. Neuron 17, 595±606.
Hirano, M., and Goldman, J.E. (1988). Gliogenesis in the rat spinalElectrophysiology
cord: evidence for the origin of astrocytes and oligodendrocytesCells wererecorded at room temperature with z5 MVpatch pipettes
from radial precursors. J. Neurosci. Res. 21, 155±167.containing (in mM) 125 KF, 15 KCl, and 11 EGTA (pH was adjusted
Hunter, K.E., and Hatten, M.E. (1995). Radial glial cell transformationto 7.2 with KOH). The recording saline contained (in mM) 140 NaCl,
to astrocytes is bidirectional: regulation by a diffusible factor in5 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose (pH was adjusted
embryonic forebrain. Proc. Natl. Acad. Sci. USA 14, 2061±2065.to 7.4 with NaOH). Current signals were amplified with an Axopatch
200B amplifier, sampled at 5 kHz, filtered at 2 kHz, stored, and Kalyani, A., Hobsen, C., and Rao, M. (1997). Neuroepithelial stem
analyzed on an IBM clone computer using pClamp 5.5 software cells from the embryonic spinal cord: isolation, characterization,
and clonal analysis. Dev. Biol. 186, 202±223.(Axon Instruments, Foster City, CA) and Webfoot (Biodiversity, Park
City, UT). Kilpatrick, T.J., and Bartlett, P.F. (1993). Cloning and growth of
multipotent neural precursors: requirements for proliferation and
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